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D10414 ReducedEnergyIntakeIstheCsueeofWeightLoseinCHFPstiente
M.J.Toth,E.T.Poehlman,M.L.Fisher,S.S.Gottlieb.Urrivereifyoffvfary/and
School of Meal,Balfimore, MD, USA
Themechanismof “cardiaccachexia”in patientswithcongestiveheartfail-
ure (CHF)is uncertain,with eitherincreasedenergymetabolism(perhaps
relatedto neurohormonalactivation)ordecreasedintakeconsideredaspos-
sible sourcesof obsetwsdweightloss.Observationsof increasedresting
metabcdic rate have lad to suggestions that increased caloric requirements
cauae cardiac cechexia, but total daily energy expenditure (TOTAL)haa
neverbeen aeseased.We thereforemeasuredTOTAL(by the doublyla-
beiladwatertechniqueover 10 days,kcellday)in 12 elderlyptswith CHF
& cechexia(Cach,definedas a lossof > 10%of premorbidweight),13
non-cachecticpatients(NoCach),& 50 healthyelderlycontrols(Nml).Free
livingphyaicelactivity(Phys,keel/day)wascalculated.We alsocompared
weight(Wt,kg, serumalbumin(alb,@dI),fat freemess&fat mess(FFM&
FAT,kg, as determinedby dualenergyX-rayabsorptiometry).wherelp <
0.05v.thetwoothergroups:
Total Phys Wt alb FFM FAT
Cach 1870 +3478 269+ 307 62 i 14* 4.0*4* 50&8* 12l9*
CHF 2349 +545 416 * 361 64& 13 4.3 i 0.4 59*5
Nml
25& 11
2543&449 728*374” 78k 15 58*9 21&8
Aaexpected,thepatientswithcachexiahadlowerFFM& FAT.Theywere
moreill, withworseejectionfraction,peakV02, & NYHAclass (11:2,111:6,
IV:4as comparedto 11:7,111:5,IV:I). Dailyenergyexpenditurewas lower
in cachacticpetientethan in non-cachecticor healthycontrols.Differences
in dailyenergyexpenditurewereprimarilydueto lowerfree-livingphysical
activity.
We concludethat reducedenergyintake,notelevatedenergyexpendi-
ture,ietheceuaeof weightlossin CHFpatients.
11041-51 MICTriel:MetOprololinpstientewith Miidend
ModerateCongestiveHeartFeilure.Effecteon Left
VentricularFunctionendCardiopulmonary
ExerciseTesting
S.Genth-Zotz,H.Darius,R.J.Zotz,M.Sigmund1,C. Kallen1,P.Hanrath1,
D.Hartmann2,F.Waagstein3.N.Treese,J. Meyer.Il. Medical Clinic,
Johannes Gutenbarg-Univera@ Mainz, Gemranx 1fWVTHAachen,
Germanx 2 UniklinikKdln, GermanH 3 Wallenbeg Laboreto% Sweden
Beta-blockertherapyieknownto producea functionalbenefitin congestive
heartfailure(CHF)in patients(pts)with idiopathicdilatedcardiomyopathy
(DCM)aswellasanimprovementinsubmaximalexercisecapacity.Theaim
of thisstudywasto aeseasif similareffectscouldbe obsewadfor ptswith
iachemicheartdesease(IHD)NYHA11-1[1aftera six monthatherapywith
metoprolol(M),a ~1-selacfivereceptorblocker,in additionto conventional
therapycomparedto placebo(P).
Methodsand Resu/ts: FiftytwopatientawithCHFseconda~to DCM(26
pta)and IHD (26 pts) and a left ventricularejectionfractions 0.35 were
enrolledin the study.All patientstoleratedthe challengedoeeof 10 mg
metoprololandwerethenrandomizedto M(26)or P (26).Studymedication
was titratedover 6 weeksstartingwith 5 mg b.i.d. to 50 mg t.i.d. Iaeting
for 6 months(meandosage135mg/d).Threeptsdieddueto cerdiogenic
shock,two of these receivedplaceboand one metoprolol.6 pte did not
completethestudydueto non-compliance.Therewasa significantincreaee
inejectionfractionat rest(from0.27to0.35),submaximal(from0.28toO.38)
andfor the ejectionfractionduringmaximalexercise(from0.29to 0.41)in
the metoprololtreatedpts.If the ptswereanalyseddueto theoriginof CHF
the sameeffectswereobsetved.Wealsoobeerveda trendof reducedleft
ventricularvolumea.M treatmentre8ultedin a significantredutiionin heart
mteandan improvementin the 6- minutewalkteet(412to 452 m)andthe
02-pulse.V02-maxandV02-ATdidnotchangecomparedto baselineinthe
metoprololor in the placebogroup.Mtreatadpts reportedan improvement
of heartfailuresymptomsreflectedina decreasedNYHAclass.
Inconclusion,longtermtreatmentwithMetoprololimprovescardiacfunc-
tionandimproveaheartfailureaymptomsin patientswithDCMandIHD.
j 1041-6/ Respirator’yMUscleStf’en9thiahWreaeedin
ChronicHeartFailurebySalbutemol:A 62
Adreno-ReceptorAgonist
D. Harrfngton,T.P.Chua,P.A.Poole-Wilson,A.J.S.Coats.National Heart
and Lung Institute, Imperial College, London, UK
The respiratorymuscleweaknesspresentin chronicheart failure (CHF)
maylimitexercisecapacity.Oml lowdosesalbutamolincreasesrespiratory
musclestrengthin nomralcontrolsand may thus havea role in CHF.In
a randomiseddoubleblindplacebocontrolledstudy12 maleCHFpatients
(age61.9k 2.4 y, LVEF27 + 3% (mean+ SEM))weregivenaalbutamol
slowrelease8 mgbdor placebofor threeweeks.Weassessedreepiratoiy
musclestrength,quadriceps(q) cross-sectionalarea ([CSA]CT scanmid
femur),andstrength,peakoxygenconsumption(VOZ),spirometry,andthe
frequencyof ventriculararrhythmias.Resu/ta.’ Maximumexpimtorymouth
presaurewhethermeasuredat total lung capacityor functionalresidual
capacity(FRC)increasedsignificantlywhanmmpamdto the placebogroup
(+29.7+ 10.6v-0.5 + 7.5cmHzOand+31.2+ 5.4v 0.2f 4.0cmH20both
p < 0.05).Maximalinspiratotypressuresshoweda trendtowardsincreasing
whenmeaeuredfrom residualvolumeor FRC(–22.8 + 9.5 v –6.2 + 3.6
cmH20,p = 0.14and–21.5 + 7.5cmH20v –3.5• 3.4cmHzOp = 0.054).
Therewas no changein q strength,qCSA,peak V02, in the frequency
of ventriculararrhythmiasor spirometty.Conclusions: Salbutemolincreases
respiratorymusclestrengthin CHFbutdoesnot increaseexercisecapacity.
11041-19\ ForearmVascularResponaasDuringDynamic
LegExercisein PatientaWithChronicHeart
Failure
J.J.Atherton,L.G.Dryburgh,H.L.Thomson,T.D.Moore,G.W.F.Muehle,
L.E.Fitzpatrick,K.N.Wright,M.P.Frenneaux.Department of Medicine,
University of Chm.errsland,Brisbane, Australia
Previousstudiesassessingvascularresponsesin non-exercisingbedsdur-
ingexercisein patientswithchronicheartfailure(CHF)haveyieldedvarying
resultsfromattenuatedto exaggemtedvaaoconstriction.We hypothesized
that the degreeof exercise-inducedconstrictionin non-exercisingvascular
bedsisrelatadtothehemodynamicseverityoftheheartfailure.Weasseased
forearmvascularresistance(FVR)uaingvenous-occlusionplethysmography
duringsemi-erectcycleexercisein 17 CHFpatientswith LVEF< 35%(49
+ 10 yrs; 15 male)and 21 controlsubjects(55 + 10 yre, 17 male).Right
heartcatheterisationand radionuclideventriculographywere performedin
all patients.
Resu/ts:(mean+SD)CHFpatientehadhigherFVRatrest(l16&54cf.81
+48 U,p < 0.05)andmaximalexercise(292+263 cf. 160+82 U,p < 0.06)
thanthe controlsubjects.However,the % changein FVRduringexerciae
wassimilarin patientsandcontrolsubjects(+146& 145cf. +116& 107,p
= NS).Therewerelinearcorrelationsbetween% changeFVRand reating
meanrightatrialpressure(r = 0.64,p < 0.01),pulmonarycapillarywedge
pressure(r= 0.59,p < 0.05),pulmonaryarterialpressure(PAP)(r= 0.85,p
< 0.001),cardiacindex(r = –0.54, p c 0.05),systemicvascularresistance
(r= 0.62,p < 0.05)and pulmona~vascularresistance(PVR)(r= 0.85,p
< 0.001).PatientawhosePAPwas greaterthan the meanfor all patients
developeda higher%increasein FVRthanthe remainingpatients(+280&
127cf.+42+ 80,p= O.001)andthecontrolsubjects(p < 0.01).Therewasno
correlationwithLVEF.Thedegreeof vasoconatricfioni non-exercisingbada
duringexercisein patientswith CHF is relatedto restinghemodynamics,
especiallyPAPand PVR.This mayexplainthe varyingresultsobtainedin
otherstudies.
m104120 Aaseaamantof ExertionaiMuacleAnaerobicMetabolismbyNearInfraredSpectroscopyin
ChronicHeariFailura
U.Corra,F.DeVito,R.Colombo,E. Bosimini,A. Mezzani,G. Minuco,
P.Giannuzzi.Cardiology Division, S. Maugeti Foundation, RCCS, Veruno,
Italy
NearInfraredSpectroscopy(NIRS)isa noninvasivemethodof investigating
exertionalchangesinmuscleoxygenation,thatreliesontheopticelpropetiies
of hemoglobin-myoglobin.Bothoxygenatedanddeoxygenatedhemcglobin-
myoglobinabsorblightat610nm,whereasdeoxygenatadstatesalaoabsorb
light at 750 nm. The 750-810 nm signal ia used to assess the trend in
hemoglobin-myoglobinoxygenation,andconsequentlymuscleoxygenation.
The aimsof the studywere: 1) to evaluatethe relationbetweenNIRS
measurementsandvenouslactateproductionduringexercise,2) to explore
the abilityof NIRSin predictinglacticanaerobicthreshold(IAT) in chronic
heartfailure(CHF)patients(pts).Twenty-fiveCHFpts, clinicallystable,in
NYHAclass1-11,werestudied:themeanageandEFwere57 & 2 yearaand
24 k 7%,respectively.Ptsperformeda symptom-limiteduprightincremental
ergometrictest (10wattincrementsoncea minute)withsimultaneousNIRS
measurements(rightvastusIateralismuscle)and femoralvenouslactate
determination(everytwominutesduringexercise).All testswerelimitedby
fatigueor breathlessness:meantotal workcapacitywas 105 + 37 watts.
A high individualcorrelationbetweenexertionalNIRSmeasurementsand
venouslactateconcentrationwasobserved:meanr = 0.87A 03 (p < 0.01),
range0.83to 0.99.TheLATwasdetectedin 17pts(68%)andin 14of them
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(82%)a non linear downward shift in the NIRS signal was observed. In these
ptsthe NIRS signal breakpoint wascloselyassociated with the LAT,occurring
less than one minute before. On the contrary, in all pts without a detectable
UT (8pts), a linear downward shift in the NIRS signale was observed.
In conclusion, NIRS measurements are well related to exertional venous
lactate production. NIRS can be used as a noninvasivetool for predicting the
appearance of the lactic anaerobic threshold during incremental exercise in
CHF pts.
m104121 ReducedMuscleBulkIncreeeestheVentilstoryReeponseto ExerciseinChronicHesrtFsilure
D. Barrington, A.L. Clark, P.A. Poole-Wilson, A.J.S. Coats. Nationa/ f-fearf
and Lung Inst, Imperial College, London, UK
Aims.’ The slope of the relationship between ventilation (VE) and carbon
dioxide production (VCOZ) ie increased in chronic heart failure (CHF). This
has been explained by an increase in dead space ventilation secondary
to impaired right ventricular function. We hypothesised that exercising a
smaller muecle mass would lessen the demands on right ventricular function
and should decrease this slope. Methods.’ 12 male CHF patients (age 60
& 2 y (mean + SEM)) performed in random order maximal exercise tests
using a cycle ergometer, with either both legs, one leg or both arms. The
VG’VCOZslope was calculated from the data of the entire test. Results.’The
VWVC02 slope was significantly lower in two and one legged exercise than
arm exercise. The slope tended to be higher in one legged exercise when
compared to two legged (31.6 +2.4 v33.4 + 2.5 v37.5 =E2.7), P <0.001 two
l~svarms, P= O.09twoleg vone leg). Tharewas no difference in respiratory
exchanga ratio at peak exercise between different tests. These differences
remained if the VEiVC02 slope was calculated from data obtained prior to
the anerobic threshold. Conclusion: Increased dead space ventilation due to
limiting right ventricular function is unlikely to explain the increased VErVC02
slope obsewed in CHF. The effect of a reduced exercising muscle mass
on the VEfVC02 slope suggests that stimulus to ventilation specific to the
exercising muscle may explain the observed differences.
I 1041-22] Dru~-lnducedchsn~esof~xe~cise~sPsciW
CorreletewithExerciseHemodynsmicsin Hesrt
Fsilure
M. Matre, S. Nodari, D. Raccagni, M. Garbellini, M. Grigolato, F. Rosselli,
L. Dei Cas. Chair of Cardio/ogM University of Brescia, /fa/y
Drug induced changes in resting hemodynamice (hem.) are not related to
those in exercise (ex) capacity in pts with heart failure (HF); however, the
role of changes in ex hemo has not been assessed, yet. 38 pts with HF
were evaluated by hemo monitoring with concomitant cardiopulmonary ex
testing before and after acute and chronic therapy with carvedilol (n = 20)
or ibopamine (n = 18), associated to digitalis, furosemide and ACE-I. At
baseline, resting cardiac index (Cl), systemic vascular resistance (SVR) and
pulmonaty wedge pressure (PWP) averaged 2.4 + 0.7 Lf/min/M2, 1633 +
433dyn*s*cm-6 and 17 + 10 mHg; at peakex, Cl, SVRand PWP were 5.3 +
1.3,832 +250 and 41 & 13, respectively. PeakV02 was 16 + 3 ml/Kg/min at
bsseline and did not significantly change after drug administration. Individual
changes, however, ranged from –26 to +52%, acutely, and from –28 to
+33%, chronically. Changes of peak V02 were not related with resting hemo.
In contrast, they were related with percent changes of peak ex Cl, SW, and
SVR after acute drug administration (r = 0.82,0.80, and –0.63, respectively)
and with changes of peak ex Cl and SVR after 4 mts therapy (r= –0.49 and
O.&l). Correlation were similar when the effects of each drug was assessed
separately. Uaing multiple regression analysis, the only determinants of the
changes of peak V02 were changes of peak ex of Cl, acutely, and of SVR,
chronically. Thus, the effects of therapy on ex hemodynamice correlate with
changes of peak ex capacity.
.~041-23\ ExerckeTrainingetCOnventionsl~orklosdCsn
NegativelyImpectonthe LeftVentriclein Hesrt
Fsilure
M. Gentilucci, M. Yeh, J. Shirani, L Blaufarb, R. Bijou, L. Demopoulos,
E.H. Sonnenblick, T.H. LeJemtel. A/berf Einstein College ofkfedicine,
Bronx, NY USA
Exercise training (ET) at conventional workload (WL), i.e. 70% of peak
aerobic capacity (V02, ml/k~min), increases peak VOZ but may accelerate
left ventricular (LV) remodeling in patients (pts) with heart failure (HF) by
chronically exposing the LV to high wall stress. Brain natriuretic peptide
(BNP, pg/ml) blood level reflects LV wall tension, and troponin I (Tl, n~ml)
level is a sensitive marker of myocardial necrosis. To evaluate the effects of
ETat conventional WLon LV remodeling, BNPand Tl levels, LVend-diastolic
volume (LVEDV,ml) and mitral regurgitation fraction (MRF, %) by 2D echo-
Doppler,were measured before and after ET for 12 wks in 8 pts with ischemic
(n =5) and hypertensive (n =3) HF. All pts were treated with angiotensin
converting enzyme inhibitors, digoxin and furosemide at constant dosages
throughout ET. Five age-matched sedentary (Seal) pts with HF of similar
severity and therapy sewed as controls.
Patienta Peak V02 BNP LVEDV MRF
ET Sed ET Sad ET Sed ET Bed
Before 15,7 16.3 163 171 2S6 306 27 26
After 20,0* 15.5 296* 1s5 265 291 39” 30
‘p c 0.05 ve berore
TI levels were above the normal value of 0.1 rig/ml in 4 of 8 ET pts and
below normal in all Sed pts. In conclusion, increasing BNP and TI levels and
MRF indicate that ETat conventional WL, although LVEDV does not change
in 3 months, can be detrimental in some pts with HF.
-[ PrognosticSignificsnceofModerateExercise
TrsininginChronicHesrtFsilure
R. Belardinelli, D. Georgiou, G. Cianci, A. Purcaro. LstitutoLancisi, Ancona,
Itafy
Recent reports have shown that exercise training (ET) improves the aerobic
capacity of patients with chronic heart failure (CHF). However, the prognostic
significance of this favorable effect has not been defined. Aim of the present
study was to determine whether moderate ET has a favorable effect on
outcome of patients (pts) with CHF. Eighty-eightpts (59 + 14 yeare, 78 men,
10 women) with CHF in stable condition and sinus rhythm were randomized
into 2 groups. A group (T= 48) underwent ET at 60% of peak V02, initially
three times aweekfor8 weeks, then fwiceaweekforone year. A group (NT=
36) wasnotexercised. At baseline, 2ndand 14thmonth all patients underwent
an incremental exercisetest with gas exchange analysie on aeycle ergometer
until exhaustion. At same times, a thallium myocardial scintigraphy using a
stress-redistribution-reinfectionprotocol was performed in 35 trained pts and
25 controls. Thallium uptake was scored from O (normal) to 4 (absent).
Medications ware not altered throughout the study. All pts completed the
protocol. Changes were obsewed only in trained pts. Peak V02 increased
by 18% at 2nd month (P c 0.005) and 217. at the end (P < 0.001). Thallium
activity score (TAS) ale. improved at 2nd month (24%, P < 0.001) and did
not change further at 14th. TAS was unchanged or woraened in control pts.
Follow-up Iaeted 2 years. Major cardiac events occurred in 18Y0of trained
pts and 47% of controls (P < 0.001). Stepwise logistic regression showed
that ET was associated with lower morbidity and mortality (P <0.001 for
both). Independent prediqtoraof events were age, changes in peak V02 and
changes in thallium activity score. In conclusion, pts with CHF who undergo
moderate ET have a better outcome than pte with CHF who have sedentary
life style.
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/ 1042-115I TheEffectsofVentriculsrHypeftrophyOn
Hemodynsmicsof MechanicalHeartValve
Prostheses:InVitroStudies
R.S. Heinrich, S.R. Hashim, A.E. Ensley, D.E. Gibson, A.P. Yoganathan.
Georgia Tech,Atlanta, GA, USA
In patients with left ventricular hypertrophy, blood that approached an aortic
valve prosthesis may be partially obstructed by the hypertrophied eeptum.
The purpose of this study was to use controlled in vitro experiments to deter-
mine the effeef of left ventricular hypertrophy on the hemodynamic function
of specific mechanical hearf valve prostheses. St. Jude (SJM) bileaflet and
Medtronic-Hall (MH) tilting disc valves (21 mm), were studied in each of
four in vitro models. The first model consisted of a straight entrance section
upstream of the valves. Subsequent modele had increasing angles of 15,30
and 45 degrees between the upstream section and the downstream section.
These models altered the momentum vector at the entrance to the valvee.
Steady and pulsatile experiments were performed and valve orientation was
altered to determine their effects on mechanical work. Pressure drop, flow
